Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Bi-level switching with power packs
Information processing apparatus and display control method
Data communication apparatus, method of controlling the same, program, and storage medium
Systems and methods for analyzing telecommunications invoices for payment
Early kill removal graphics processing system and method
Beaconing and superframe structure for millimeter wave wireless technologies
Atmospheric treater with roller confined discharge chamber
  Randomly Featured Patents
Pyridone monoazo compound having vinylsulfone type fiber-reactive group
Apparatus and method for adjusting position of electronic component
Low wash water silver halide film processor
Two-dimensional photonic crystal optical multiplexer/demultiplexer using boundary reflection
Method and apparatus for speech recognition using domain ontology
System and method of compensation for device mounting and thermal transfer error
Germanium plant named `Sanwhite`
Electromagnetic target generator
Case separating apparatus